Send to

Choose Destination
Nat Clin Pract Oncol. 2007 Jul;4(7):415-23.

Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer.

Author information

Channing Laboratory, Brigham and Women's Hospital, Boston, MA 02115, USA.


It is increasingly being recognized that breast cancer does not represent a single homogeneous disease; instead, the hormone-receptor status defines important clinical and etiologic differences. We review the epidemiologic data on differences in risk-factor associations by hormone-receptor status and highlight major trends in the literature. We discuss the development and evaluation of breast cancer risk models, with a focus on the Rosner and Colditz model, which can separately estimate the risk of hormone-receptor-positive and hormone-receptor-negative breast cancers. We also discuss the clinical implications of accounting for hormone-receptor status in breast cancer risk-prediction models.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center